This podcast features a panel discussion from the 2024 PODD Conference with pharma and biotech leaders about formulation and physical approaches to achieve targeted brain delivery. The panelists discuss challenges and updates, patient acceptability and recent approvals for a variety of approaches including:

• Nose-to-brain delivery
• Introcerebroventricular injections
• Blood-brain-barrier disruption via excipients
• Implantable approaches
• Combinations

To learn more about the PODD conference, please visit Drug-Delivery.org.